Skip to content

Carob bean gum and reflux in infants

Effects of different levels of carob bean gum in Friso Comfort on lower esophageal reflux

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20846
Enrollment
30
Registered
2013-12-24
Start date
2013-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uncomplicated oesophageal reflux, infants 2-6 months, oesophageal pH monitoring

Interventions

The included infants will be, based on study entry number, at random allocated to one of three study infant formulae. These products have the same basic composition, but differ in amount and type (hot

Sponsors

Saint Marina Hospital, Varna, Bulgaria
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) 2-6 months of age with a score of I-GERQ more than 7, as defined by Orenstein. 2) Proven acid or non-acid reflux with pH-Z ambulatory 24-hour pH and impedance recorder 3) The signed informed consent by one/both parents / legal guardian 4) Available throughout the study period 5) Parents/guardian have the mental ability to understand and willingness to fulfil all the details of the protocol

Exclusion criteria

Exclusion criteria: 1) Preferred no breastfeeding at time of inclusion. When the inclusion of participants in not possible because of this criteria, 25% breast milk of total daily milk intake is allowed. 2) Cow’s milk protein allergy diagnosed as positive IgE and/or positive prick reactions to cow’s milk and/or eosinophilia in differential blood count, 3) Preterm birth, 4) Infants with a history of wheezing, aspiration pneumonia, apnea. 5) Anemia with hemoglobin less than 90g/l, as checked by finger prick. 6) Gastro-intestinal bleeding, diarrhoea 7) Infants with laryngitis, 8) Urinary tract infection 9) Weight gain for the last month of more than 100 g/week 10) Apparent life threatening events, 11) Neurologic deficits, 12) Infants with a known organic or metabolic cause of reflux, 13) Infants already receiving anti-reflux formulae or medications that can affect gastrointestinal tract motility.

Design outcomes

Primary

MeasureTime frame
Components of 24-h Oesophageal pH Monitoring using a Digitrapper pH-Z ambulatory 24-hour pH and impedance recorder: • Percent total time pH&#8201;<&#8201;4 • Percent Upright time pH&#8201;<&#8201;4 • Percent Supine time pH&#8201;<&#8201;4 • Number of reflux episodes • Number of reflux episodes &#8805; 5 min • Longest reflux episode (minutes) • SI (symptom index for reflux) • SSI (symptom sensitivity index) • SAP (symptom associated probability)

Secondary

MeasureTime frame
The nuimber of visible refluxes and stool consistency as monitored by the parent using a 3-days diary.

Contacts

Public ContactAnne Schaafsma

P.O.Box 226

anne.schaafsma@frieslandcampina.com+31 (0)58 2992424

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)